Cost-Effectiveness Of Denosumab In The Treatment Of Postmenopausal Osteoporosis (Pmo) Women In Mexico At High Risk Of Fractures And Intolerant To Oral Bisphosphonates
Abstract
Authors
R. Arocho R. Rivera Hurtado G. Salinas Escudero